The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.
 
David Stephen Shulman
No Relationships to Disclose
 
Priscilla Merriam
No Relationships to Disclose
 
Edwin Choy
Consulting or Advisory Role - Adaptimmune; Bayer; Daiichi Sankyo; Epizyme
Research Funding - Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Exelixis (Inst); Immune Design (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst)
 
Lillian M. Guenther
No Relationships to Disclose
 
Kerri Cavanaugh
No Relationships to Disclose
 
Pei-Chi Kao
No Relationships to Disclose
 
Andrew Posner
No Relationships to Disclose
 
Grace Fairchild
No Relationships to Disclose
 
Emma Barker
Consulting or Advisory Role - Blueprint Medicines
Travel, Accommodations, Expenses - Deciphera
 
Kimberly Stegmaier
Leadership - Auron Therapeutics
Honoraria - Bristol Myers Squibb Foundation
Consulting or Advisory Role - AstraZeneca; Auron Therapeutics; Novartis Institutes for BioMedical Research; Rigel
Research Funding - Kronos Bio; Novartis; Novartis Institutes for BioMedical Research
 
Brian D. Crompton
Employment - Acceleron Pharma (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Research Funding - Gradalis
 
Wendy B. London
Consulting or Advisory Role - Jubilant Radiopharma; Merck
Research Funding - Agios; Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc